4 months 5% foam min + finasteride - 20 years old
    Progress Pictures 3/25/2024

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    πŸ’§ Minoxidil (topical) 5% 1x daily 4 months
    πŸ’Š Finasteride (oral) 1mg 1x daily 4 months
    the tone is πŸ˜€ positive with significant hair regrowth results.

    Other terms

    A 20-year-old user experienced significant hair regrowth after using 5% minoxidil foam and finasteride for four months, starting to see results after two months with no side effects. They also cut off damaged hair ends, wash their hair every other day, and advise managing stress to improve hair loss outcomes.
    View this post in the Community β†’

    Similar Community Posts Join

    6 / 1000+ results

    Related Research

    6 / 1000+ results
      Clinical Trials and Hair Loss

      research Clinical Trials and Hair Loss

      1 citations, July 2018 in “Elsevier eBooks”
      Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.
      Male Androgenetic Alopecia

      research Male Androgenetic Alopecia

      100 citations, April 2010 in “Expert Opinion on Pharmacotherapy”
      Hair loss in men treated best with early medication or transplant, new treatments researched.
      Management of Hair Loss

      research Management of Hair Loss

      74 citations, April 2005 in “Dermatologic Clinics”
      Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.
      The Modern Treatment of Androgenetic Alopecia

      research The Modern Treatment of Androgenetic Alopecia

      February 2017 in “Vestnik dermatologii i venerologii”
      Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.